AI-Based Clinical Trials Solution Provider Market: Segmented: By Clinical Trial Phase (Phase-I, Phase-II, Phase-III), By Therapeutic Application (Oncology, Cardiovascular Diseases, Neurological Diseases or Conditions, Metabolic Diseases, Infectious Diseases, Others), By End User (Pharmaceutical Companies, Academia, Others), And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2033

February 2023 | 284 pages | ID: A3650A116C46EN
Fatpos Global

Abstracts

Market Overview

The report, AI-Based Clinical Trials Solution Provider Market- Analysis of Market Size, Share & Trends for 2014 - 2022 and Forecasts to 2032, was published by Fatpos Global and is expected to reach Market Value. Fatpos Global conducted a study. The report, in order to provide a thorough understanding of the global market, emphasises the detailed understanding of some key factors, such as size, share, sales, forecast trends, supply, production, demands, industry, and CAGR.

The AI-Based Clinical Trials Solution Provider Market grew from USD 2.56 billion in 2022 to USD 16.0 billion by 3032, exhibiting a CAGR of 18.2% during the forecast period.

Key Companies Profiled

• Deep Lens Inc.
• Hematology-Oncology Associates of CNY
• GlaxoSmithKline plc
• Genentech
• AiCure LLC
• Aiforia
• Antidote Technologies Inc.
• Avantor Inc.
• Deep 6 AI
• Innoplexus Consulting Services Pvt Ltd
• Intelligencia.ai
• MEDIAN Technologies
• Pharmaceutical Pipeline Enhancement Strategies LLC
• Saama Technologies Pvt Ltd
• Simplifai AS
• Other Prominent Players

AI-Based Clinical Trials Solution Provider Market: Segmentation

• By Clinical Trial Phase
• Phase-I
• Phase-II
• Phase-III
• By Therapeutic Application
• Oncology
• Cardiovascular Diseases
• Neurological Diseases or Conditions
• Metabolic Diseases
• Infectious Diseases
• Others
• By End User
• Pharmaceutical Companies
• Academia
• Others
• AI-Based Clinical Trials Solution Provider Market Dynamics
• Size Supply and Demand AI-Based Clinical Trials Solution Provider Market
• Current Issues/Trends/Challenges
• Companies and Competition Market Drivers and Restraints Involved in the Market Value Chain
• The report sheds light on various aspects and provides answers to pertinent market questions. Among the most important are:
• Pre- and post-business impact analysis of COVID-19
• A thorough examination of the parent market
• Market dynamics in the industry are changing.
• Market segmentation in depth
• What is the AI-Based Clinical Trials Solution Provider Market expansion?
• Which segment had the highest AI-Based Clinical Trials Solution Provider Market share?
• Who are the main characters in AI-Based Clinical Trials Solution Provider Market?
• Historical, current, and projected market volumes and values
• Trends and developments in the industry recently
• The competitive environment
• Key players' strategies and products on offer
• Potential and niche segments, as well as geographical regions with promising growth prospects
• A balanced assessment of market performance
• Information that markets participants must have in order to maintain and expand their market footprint.

Note: Although Fatpos Global has taken great care to ensure the highest levels of accuracy in its studies, it might take some time for significant changes to the market or a particular vendor to be reflected in the research.

Contents

1 EXECUTIVE SUMMARY

2 GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET

2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3 RESEARCH METHODOLOGY

3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4 AVERAGE PRICING ANALYSIS

5 MACRO-ECONOMIC INDICATORS

6 MARKET DYNAMICS

6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7 CORRELATION & REGRESSION ANALYSIS

7.1. Correlation Matrix
7.2. Regression Matrix

8 RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE

9 RISK ANALYSIS

9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10 GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET ANALYSIS

10.1. Porters Five Forces
  10.1.1. Threat of New Entrants
  10.1.2. Bargaining Power of Suppliers
  10.1.3. Threat of Substitutes
  10.1.4. Rivalry
10.2. PEST Analysis
  10.2.1. Political
  10.2.2. Economic
  10.2.3. Social
  10.2.4. Technological

11 GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET

11.1. Market Size & forecast, 2020A-2030F
  11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

12 GLOBAL ONCOLOGY PHARMACEUTICALS MARKET: MARKET SEGMENTATION

12.1. By Regions
  12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Type: Market Share (2020-2030F)
  12.2.1. Chemotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.2. Targeted Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.3. Immunotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.4. Hormonal Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Indication: Market Share (2020-2030F)
  12.3.1. Lung Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.2. Stomach Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.3. Breast Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.4. Prostate Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By End user: Market Share (2020-2030F)
  12.4.1. Specialized cancer treatment centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.4.2. Hospitals Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.4.3. Retail Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

13 COMPANY PROFILE

Deep Lens Inc.
Hematology-Oncology Associates of CNY
GlaxoSmithKline plc
Genentech
AiCure LLC
Aiforia
Antidote Technologies Inc.
Avantor Inc.
Deep 6 AI
Innoplexus Consulting Services Pvt Ltd
Intelligencia.ai
MEDIAN Technologies
Pharmaceutical Pipeline Enhancement Strategies LLC
Saama Technologies Pvt Ltd
Simplifai AS
Other Prominent Players

14 CONSULTANT RECOMMENDATION

**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.